Internal Medicine Grand Rounds-16462-------10/15/2013, Stanton Gerber Hall
'Immunotherapy of Metastatic Castrate Resistant Prostate Cancer (mCRPC) with Sipuleucel-T: Fundamental Concepts', Mehmet Hepgur, M.D.
Dr. Hepgur reports there is NOT any relevant financial interest/arrangement of affiliation with one or more organizations which could be perceived as a real or apparent
COI in the context of this presentation. This Continuing Medical Education activity has not received support from any commercial source.
How well did this activity meet the stated learning objectives?ExcellentAbove AverageAverageBelow AveragePoor
Review the Fundamentals of Cancer Immunotherapy          
Discuss the immunotherapy methods of prostate cancer          
Please rate this presentation:ExcellentAbove AverageAverageBelow AveragePoor
Balanced, Objective, and Evidence Based          
Appropriate for intended audience          
Rate your level of knowledge BEFORE this educational activity          
Rate your level of knowledge AFTER this educational activity          
How well did this activity address a need you have in your practice          
Free of commercial bias    
Based on what you heard today:
Which physician attributes (core competencies) did the speaker incorporate into their presentation? Please choose all which apply:
Patient Care
Practice-Based Learning & Improvement
Medical Knowledge
System-Based Practice
Interpersonal & Communication Skills
82 y/o patient with metastatic prostrate cancer currently on ADT (leuprolide & bicalutamide) with presents with progressive bone pain due to bone mets requiring opioids, has new lung
metastasis, Testosterone<50, PSA: 322, Hgb: 8.5, LDG: 750, SAP: 355. What initial therapy would you recommend?
A). Sipulecuel-T-- B). Enzalutamide--- C). Abiraterone--- D). Docetaxel--- E). Mitoxantrone
Correct answer is: E          
What new information/strategy do you plan to implement into your clinical practice?
What challenges or barriers might prevent you from implementing this new information/strategy?
What topics do you feel need to be addressed in future CME activities?
If you have questions, concerns, or comments about this activity, please contact: Barbara Sucher, M.B.A., Associate Dean for CME or 423.439.8081. Form Revised 4-2013